February 1, 2010

Clinical Trials: A Phase 1 Dose Finding Study of the Safety and Pharmacokinetics of XL184 Administered Orally in Combination With Temozolomide and Radiation Therapy in the First Line Treatment of Subjects With Glioblastoma

Sponsor and Collaborators

Exelixis

Contact

Continue Reading

PRA Contact Line 1-800-251-8124

Principal Investigators

Multiple throughout the United States

ClinicalTrials.gov Identifier

NCT00960492

Topics:

Clinical Trials

Next post in Brain Cancer Clinical Trials

Clinical Trials: NYU 05-40 PBMTC ONC-032P:High Dose Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue (ASCR) Followed by Continuation Therapy With 13-Cis-Retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors